Eblasakimab improves multiple disease measures in adult patients with moderate-to-severe atopic dermatitis in a randomized, double-blinded, placebo-controlled, Phase 1 study
Karen A. Veverka, Josemund Menezes, Steven Tien Guan Thng, Melinda Gooderham, Eric Simpson